Just wonder if anyone participates in Window 2 clinical trial of MD Anderson where patients receive Ibrutinib in the first 4 months, combine with Rituximab and add Venetoclax in month 5. Chemo will be followed if in the medium and high risk. Then another 2-3 years in maintenance with Ibrutiniv, Venetoclax and Rituximab.
Any idea or advice, please whether to join this trial? How is it compared with chemo + transplant.
One of the thing if you join trial, you have to have CT scan every month, ehich is harmful as well?
splenic marginal zone lymphoma treatments
NH Lymphoma treatments
Gazyva treatment for follicular lymphoma
The Report : Stage 4, Cell B, Follicular, Non Hodgkin's Lymphoma, 5-16-18
